Last reviewed · How we verify

NCT07126795

Magnesium Sulfate in Pediatric Burn Dressing Changes

Not yet recruiting Phase 1 Last updated 22 August 2025
What this trial tests

Phase 1 trial testing magnesium sulfate in Pediatric Burns in 10 participants. Not yet recruiting.

Timeline
1 January 2026
Primary endpoint
1 December 2026
1 January 2027

Quick facts

Lead sponsorHennepin Healthcare Research Institute
PhasePhase 1
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designsingle group
Maskingtriple
Primary purposetreatment
Enrollment10
Start date1 January 2026
Primary completion1 December 2026
Estimated completion1 January 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Hennepin Healthcare Research Institute

Who can join

Adults 3 to 18, any sex, with Pediatric Burns. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prospective feasibility trial utilizing adjuvant magnesium sulfate for analgesia/sedation during pediatric sedated burn dressing changes, which is ultimately hypothesized to decrease ketamine and/or sedative requirements.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of magnesium sulfate

Trials testing the same drug.

Other recruiting trials for Pediatric Burns

Currently open trials in the same condition.

Other Hennepin Healthcare Research Institute trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07126795.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing